FDA Inspection 1197386 — Corden Pharma Fribourg SA

Corden Pharma Fribourg SA — FEI 3009018997

The FDA completed an inspection of Corden Pharma Fribourg SA on February 3, 2023 in Villars-Sur-Glane. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
February 3, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Villars-Sur-Glane (Switzerland)

Citations

IDCFRDescription
202721 CFR 211.192Investigations of discrepancies, failures
439121 CFR 211.180(e)(2)Items to cover on annual reviews